Abstract
The objective of this study was to determine: (1) the diagnostic value of antiperinuclear factor (APF), (2) the types of immunoglobulins involved in the reaction and (3) the presence of the antibody in paired samples of serum and synovial fluid (SF). We studied 408 serum samples from the following: healthy controls (n=68), patients with rheumatoid arthritis RA; n=160, 106 RF-positive and 54 RF-negative and patients with other rheumatic diseases (n=180). We examined paired serum and SF samples in 27 patients (8 with RA and 19 with other rheumatic conditions). APF was determined by an indirect immunofluorescence assay. A group of 30 APF-positive serum samples was incubated with fluorescent-labelled antisera against IgG, IgM and IgA independently. APF was positive in 55.7% of patients with RF-positive RA, in 35.2% of patients with RF-negative RA, in 11.1% of patients with other rheumatic diseases and in 5.9% of healthy controls. Statistical differences were found between RF-positive RA and the other three groups (P=0.02, P=0.0001, P=0.0001, respectively) and between RF-negative RA and the groups of other rheumatic diseases (P=0.0001) and healthy controls (P=0.005). The specificity of the test for RA was 90.2%. APF was present in three SF samples from RA patients (37.5%). The reaction was mediated by immunoglobulins of the IgG class in 100% of those tested, and, in addition, 30% were of IgA and 6.7% of IgM classes. We concluded that APF is a good diagnostic test that could be included in the classification criteria of RA, it can be present in SF and it is predominantly an antibody of the IgG class.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnett FC, Edworthy SM, Block DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Michet CJ (1993) Psoriatic arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 974–984
Wollheim FA (1993) Enteropathic arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 985–997
Gran JT, Husby G (1987) Seronegative rheumatoid arthritis and HLA-DR4: proposal for criteria (editorial). J Rheumatol 14:1079–1082
Schrohenloher RE, Koopman WJ (1993) Rheumatoid factor. In: McCarty DS, Koopman WJ (eds) Arthritis and allied conditions. A textbook of rheumatology. Lea & Febiger, Philadelphia, pp 861–876
Young BJJ, Mallya RK, Leslie RDG, et al. (1979) Antikeratin antibodies in rheumatoid arthritis. BMJ 2:97–99
Osung OA, Chandran M, Holborow EJ (1982) Antibodies to intermediate filaments of the cytoskeleton in rheumatoid arthritis. Ann Rheum Dis 41:69–73
Nienhuis RLF, Mandema E (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23:302–305
Janssens X, Veys EM, Verbruggen G, Declercq L (1988) The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. J Rheumatol 15:1346–1350
Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russel G (1981) Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis 40:263–266
Muñoz-Fernández S, Alvarez Doforno R, Balsa A, Fontán G, Gijón Baños J (1994) Factor antiperinuclear: criterio de positividad y dilución óptima de los sueros problema. Rev Esp Reumatol 21:13–17
Alarcón GS (1993) Seronegative polyarthritis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions. A textbook of rheumatology. Lea & Febiger, Philadelphia, pp 1013–1020
Wilske KR, Healey LA (1989) Remodeling the pyramid-a concept whose time has come (editorial). J Rheumatol 16:565–567
Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591
Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M (1992) Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 51:743–746
Smolen JS, Hassfeld W, Steiner G (1990) Anti-RA 33 — a new autoantibody characteristic of rheumatoid arthritis. Isr J Med Sci 26:693–694
Sondag-Tschroots IRJM, Aaij C, Smit JW, Feltkamp TEW (1979) The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis 38:248–251
Kataaha PK, Mortazavi-Milani SM, Russell G, Holborow EJ (1985) Anit-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 44:446–449
Youinou P, Le Goff P, Dumay A, Lelong A, Fauquert P, Jouquan J (1990) The antiperinuclear factor. I. Clinical and serologic associations. Clin Exp Rheumatol 8:259–264
Westgeest AAA, Boerbooms AMTh, Jongmans M, Vandenbroucke JP, Vierwinden G, Van de Putte LBA (1987) Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 14:893–897
Hoet RMA, Boerbooms AMTh, Arends M, Ruiter DJ, Van Venrooij WJ (1991) Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalization of the perinuclear factor and profilaggrin. Ann Rheum Dis 50:611–618
Vivino FB, Maul GG (1990) Histologic and electron microscopic characterization of the antiperinuclear factor antigen. Arthritis Rheum 33:960–969
Manera C, Franceschini F, Cretti L, Braga S, Cattaneo R (1994) Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor. J Rheumatol 21:2021–2025
Veys EM, De Keyser F, De Vlam K, Verbruggen G (1990) The antiperinuclear factor (editorial). Clin Exp Rheumatol 8:429–431
Youinou P, Seigneurin JM, Le Goff P, Dumay A, Vicariot M, Leolong A (1990) The antiperinuclear factor. II. Variability of the perinuclear antigen. Clin Exp Rheumatol 8:265–269
Feltkamp TEW, Boerbooms AMTh, De Keyser F et al. (1990) Antiperinuclear factor-standardization program. Clin Rheumatol 9:112–113
Smit JW, Sondag-Tschroots IRJM, Aaij C, Feltkamp TEW, Feltkamp-Vroom TM (1980) The antiperinuclear factor: II. A light microscopical and immunofluorescence study on the antigenic substrate. Ann Rheum Dis 39:381–386
Hoet RMN, Voorsmit RACA, Van Venrooij WJ (1991) The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells. Clin Exp Immunol 84:59–65
Nesher G, Moore TL, Grisanti MW, El-Najdawi E, Osborn TG (1991) Correlation of antiperinuclear factor with antibodies to streptococcal cell-wall peptidoglycan-polysaccharide polymers and rheumatoid factor. Clin Exp Rheumatol 9:611–615
Muñoz-Fernández S, Alvarez-Doforno R, Balsa A, Fontán G, Gijón J (1994) Relationship between antiperinuclear factor and inflammatory activity of rheumatoid arthritis. Br J Rheumatol 33:893–894
Aho K, Von Essen R, Kurki P, Palosuo T, Heliövaara M (1993) Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 20: 1278–1281
Balsa A, Barnes J, Muñoz-Fernández S, Alvarez-Doforno R, Hall ND, Maddison PJ (1994) Antiperinuclear factor: a prognostic marker in early synovitis. Arthritis Rheum 37 [Suppl]: S332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muñoz-Fernández, S., Alvarez-Doforno, R., Cuesta, M. et al. Antiperinuclear factor: a useful test for the diagnosis of rheumatoid arthritis. Rheumatol Int 15, 145–149 (1995). https://doi.org/10.1007/BF00301771
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00301771